Patent details

EP2906253 Title: PYRROLOBENZODIAZEPINE - ANTI-PSMA ANTIBODY CONJUGATES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2906253
WO Application Number:
EP2013071341
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP13795435.0
WO Publication Number:
WO2014057113
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
11/10/2013
Grant date:
01/08/2018
EP Publication Date:
19/08/2015
WO Publication Date:
17/04/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
09/10/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/11/2020
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/08/2018
EP B1 Publication Date:
01/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
10/10/2033
Lapsed By Expiration Date:
Patent Validated Date:
20/10/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
01/08/2018
 
 

 

Name:
ADC Therapeutics SA
Address:
Route de la Corniche 3B, 1066 Epalinges, Switzerland (CH)

From:
01/08/2018
 
 

 

Name:
Medimmune Limited
Address:
Milstein Building Granta Park, CAMBRIDGE, CAMBRIDGESHIRE CB21 6GH, United Kingdom (GB)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
19/10/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
VAN BERKEL, Patricius Hendrikus Cornelis
Address:
1003 Lausanne, Switzerland (CH)

2

Name:
HOWARD, Philip Wilson
Address:
London Greater London E1 2AX, United Kingdom (GB)

Pledgee

Name:
Deerfield Partners, L.P.
Address:
780 Third Avenue, 37th Floor, 10017, New York, NY, United States of America (US)

Priority

1

Priority Patent Number:
201361784477 P
Priority Date:
14/03/2013
Priority Country:
United States of America (US)

2

Priority Patent Number:
201361784460 P
Priority Date:
14/03/2013
Priority Country:
United States of America (US)

3

Priority Patent Number:
201361784525 P
Priority Date:
14/03/2013
Priority Country:
United States of America (US)

4

Priority Patent Number:
201261712928 P
Priority Date:
12/10/2012
Priority Country:
United States of America (US)

5

Priority Patent Number:
201261712924 P
Priority Date:
12/10/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61P 35/00; A61K 47/68;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
22/21
Publication date:
02/06/2021
Description:
Lapse or annulment

2

Bulletin Heading:
MED
Journal edition number:
29/20
Publication date:
14/08/2020
Description:
Other communications

3

Bulletin Heading:
EP3
Journal edition number:
44/18
Publication date:
24/10/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
32/18
Publication date:
01/08/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201915
Publication date:
10/04/2019
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
201909
Publication date:
27/02/2019
Description:
Document reprinted after correction (B8, B9)

3

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed

4

Issue number:
201831
Publication date:
01/08/2018
Description:
Grant (B1)

Deed

Right of Pledge

Change Kind/ Decision Type:
Established
Deed Number:
RC202001210A
Date Registered:
25/06/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Het aandeel van ADC Therapeutics SA is verpand.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Pledgee(s)

Name:
Deerfield Partners, L.P.
Address:
780 Third Avenue, 37th Floor, 10017, New York, NY, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
25/10/2019
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Mewburn Ellis LLP
Filing date Document type Document Description Number of pages File Type
19/10/2018 Outgoing Correspondence Letter no formal defects 1 PDF /8/8/9/6/9/0800296988/docs/ep13795435.0_0_234684l271.pdf
09/10/2018 Claims First filed claims 4 PDF /8/8/9/6/9/0800296988/docs/ep13795435.0_1_claims20181009124601859.pdf
09/10/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /8/8/9/6/9/0800296988/docs/ep13795435.0_2_incomingcorrespondenceelectronic20181009124603206.pdf